Leadless Pacemaker Systems Market - Global Industry Analysis

Leadless Pacemaker Systems Market- By Product (Micra Transcatheter Pacing System, Nanostim Leadless Pacemaker, and Others) and By End-User (Hospitals and Ambulatory Surgical Units): Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends And Forecast, 2022 – 2028

Published Date: 29-Apr-2022 Category: Medical Device Report Format : PDF Pages: 122 Report Code: ZMR-6998 Status : Published

The global Leadless Pacemaker Systems Market accrued earnings worth approximately 55 (USD Million) in 2021 and is predicted to gain revenue of about 98 (USD Million) by 2028, is set to record a CAGR of nearly 10.1% over the period from 2022 to 2028.

Description

The global Leadless Pacemaker Systems Market accrued earnings worth approximately 55 (USD Million) in 2021 and is predicted to gain revenue of about 98 (USD Million) by 2028, is set to record a CAGR of nearly 10.1% over the period from 2022 to 2028. The study provides assessment and analysis of the Leadless Pacemaker Systems Market on a global & regional level. It offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2021 along with a forecast from 2022 to 2028 based on revenue (USD Million).

Leadless Pacemaker Systems Market: Overview

Leadless pacemaker systems are self-contained generators & electrode systems implanted directly into right ventricle of human body. The device is inserted through femoral vein transcatheter approach and needs no chest incision and sub-cutaneous generator pocket. Key benefit of leadless pacemaker system is eliminating large number of complications related to transvenous pacemakers & leads, hematoma, lead fracture, pocket infections, and lead dislodgement. Leadless pacemakers can be suited to patients having permanent atrial fibrillation due to bradycardia or those that need pacing regularly. However, leadless pacemaker systems are not appropriate for subjects requiring dual-chamber pacing. For instance, patients having particular kinds of heart block as well as sinus node dysfunction.

Global Leadless Pacemaker Systems Market

Leadless Pacemaker Systems Market: Growth Drivers

Surge in cardiovascular diseases and increase in geriatric population prone to heart ailments will create huge scope of growth for leadless pacemaker systems industry. Favorable reimbursement policies and elongated battery life has made use of leadless pacemaker systems popular in healthcare sector. Breakthroughs in pacemaker technology and growing tilt towards minimally invasive surgeries & treatment will pave a way for massive growth of leadless pacemaker systems industry in ensuing years. Supportive government laws promoting healthcare activities along with surge in allocation of funds for healthcare industry will drive expansion of leadless pacemaker systems market. Nonetheless, high implantation costs and lack of trained personnel for performing leadless pacemaker implants can pose a threat to expansion of leadless pacemaker systems industry.

Furthermore, no threat of scars & infections and MRI compatibility will translate into huge growth of leadless pacemaker systems industry. No requirement of post-operative mobility restriction will further steer growth of leadless pacemaker systems market. Product innovations and launching of new technologies in healthcare sector will create lucrative opportunities for leadless pacemaker systems industry.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Leadless Pacemaker Systems Market: Regional Landscape

North America Contributed Immensely Towards Regional Market Share By 2028

Expansion of leadless pacemaker systems industry in North America over forecasting timeline is subject to rise in occurrence of heart ailments along with swift acceptance of leadless cardiac pacemakers. Additionally, favorable compensation policies and surge in number of patients suffering from atrial fibrillation will translate into humungous growth of regional market. Apart from this, large-scale presence of giant medical device manufacturing firms in sub-continent has contributed majorly towards leadless pacemaker systems market rewards in North America.

Leadless Pacemaker Systems Market: Competitive Landscape

Key players establishing a deeper impact on leadless pacemaker systems market growth and included in report are Abbott Laboratories, Biotronik, Medtronic PLC, EBR Systems, Inc., and Boston Scientific Corporation.

The global Leadless Pacemaker Systems Market is segmented as follows:

By Product

  • Micra Transcatheter Pacing System
  • Nanostim Leadless Pacemaker
  • Others

 By End-User

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

Surge in cardiovascular diseases and increase in geriatric population prone to heart ailments will create huge scope of growth for leadless pacemaker systems industry.

 

According to Zion market research report, The global Leadless Pacemaker Systems Market accrued earnings worth approximately 55 (USD Million) in 2021 and is predicted to gain revenue of about 98 (USD Million) by 2028, is set to record a CAGR of nearly 10.1% over the period from 2022 to 2028.

North America will contribute sizably towards the global industry revenue over the projected timeline. Expansion of leadless pacemaker systems industry in North America over forecasting timeline is subject to rise in occurrence of heart ailments along with swift acceptance of leadless cardiac pacemakers.

The key industry participants leveraging industry sphere include Abbott Laboratories, Biotronik, Medtronic PLC, EBR Systems, Inc., and Boston Scientific Corporation.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed